BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
11.15
-0.25 (-2.19%)
At close: Oct 17, 2025, 4:00 PM EDT
11.10
-0.05 (-0.45%)
After-hours: Oct 17, 2025, 4:00 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $883.04 million as of October 17, 2025. Its market cap has increased by 272.78% in one year.
Market Cap
883.04M
Enterprise Value
754.48M
1-Year Change
272.78%
Ranking
Category
Stock Price
$11.15
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $883.04M, an increase of 2,210.88%. That is a compound annual growth rate of 542.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 883.04M | 257.73% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |